Literature DB >> 12370861

Acute and prolonged effects of insulin-induced hypoglycemia on the pituitary-thyroid axis in humans.

Bernd Schultes1, Kerstin M Oltmanns, Werner Kern, Jan Born, Horst L Fehm, Achim Peters.   

Abstract

Secretory activity of the pituitary-thyroid axis and thyroid hormone metabolism show characteristic changes in response to different stressors often referred to as the euthyroid sick syndrome. Hypoglycemia is an acute metabolic stressor inducing various neuroendocrine responses, the effects of which on pituitary-thyroid secretory activity so far have been entirely neglected. We performed stepwise hypoglycemic and euglycemic clamps each lasting 6 hours in 30 healthy men. To assess the potential influence of hyperinsulinemia on pituitary-thyroid hormone release, 2 different rates of insulin infusion were used for the clamps. During the hypoglycemic clamps, serum thyroid-stimulating hormone (TSH) concentration decreased in comparison to the euglycemic condition on average by 28% +/- 4% (P <.001), while serum concentration of free triiodothyronine (fT3), free thyroxine (fT4), and thyroxine-binding globulin (TBG) remained unchanged. The effect did not depend on the rate of insulin infusion. To assess the prolonged effect of acute hypoglycemia on pituitary-thyroid secretory activity, serum TSH and thyroid hormone concentrations were subsequently measured in another 15 healthy men before and 18 hours after 2 consecutive hypoglycemic clamps together lasting about 270 minutes. Compared with values before the hypoglycemic clamps, serum levels of TSH, fT3, and fT4 were found to be still reduced (by 44% +/- 6%, 12% +/- 2%, and 10% +/- 1%, respectively) 18 hours after the last hypoglycemic episode (P <.001 for all comparisons). The observed hormonal changes after hypoglycemia were not accompanied by any change in resting energy expenditure (REE). Data indicate acute as well as prolonged inhibitory influences of hypoglycemia on pituitary-thyroid secretory activity. The pattern of changes suggests that hypoglycemia exerts its influence primarily at a central, ie, pituitary and/or hypothalamic, site of the axis. Copyright 2002, Elsevier Science (USA). All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12370861     DOI: 10.1053/meta.2002.35193

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  6 in total

Review 1.  Role of the hypothalamus in mediating protective effects of dietary restriction during aging.

Authors:  Penny A Dacks; Cesar L Moreno; Esther S Kim; Bridget K Marcellino; Charles V Mobbs
Journal:  Front Neuroendocrinol       Date:  2012-12-20       Impact factor: 8.606

2.  Insulin represses transcription of the thyroid stimulating hormone beta-subunit gene through increased recruitment of nuclear factor I.

Authors:  Kee Kwang Kim; Key Sun Park; Seok Bean Song; Kyoon Eon Kim
Journal:  J Biol Chem       Date:  2010-08-04       Impact factor: 5.157

Review 3.  Regulation of peripheral metabolism by substrate partitioning in the brain.

Authors:  Cesar Moreno; Linda Yang; Penny Dacks; Fumiko Isoda; Michael Poplawski; Charles V Mobbs
Journal:  Endocrinol Metab Clin North Am       Date:  2013-03       Impact factor: 4.741

4.  Thyroid cancer risk is not increased in diabetic patients.

Authors:  Chin-Hsiao Tseng
Journal:  PLoS One       Date:  2012-12-27       Impact factor: 3.240

5.  On the role of gallbladder emptying and incretin hormones for nutrient-mediated TSH suppression in patients with type 2 diabetes.

Authors:  David P Sonne; Asger Lund; Jens Faber; Jens J Holst; Tina Vilsbøll; Filip K Knop
Journal:  Endocr Connect       Date:  2014-10-02       Impact factor: 3.335

6.  Pituitary-gonadal and pituitary-thyroid axis hormone concentrations before and during a hypoglycemic clamp after sleep deprivation in healthy men.

Authors:  Kamila Jauch-Chara; Sebastian M Schmid; Manfred Hallschmid; Kerstin M Oltmanns; Bernd Schultes
Journal:  PLoS One       Date:  2013-01-10       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.